Five Prime Therapeutics Operating Income

Five Prime Therapeutics (FPRX) currently reports a operating income of $-93M as of December 2020. That compares with $-140M in the prior-year period — up 34.6% year over year. Use the charts on this page to explore Five Prime Therapeutics's operating income history and peer comparisons.

Five Prime Therapeutics's operating income increased from $-140M to $-93M — a 34.6% year-over-year increase (period ending December 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Five Prime Therapeutics reported $-93M in operating income as of December 2020. That compares with $-140M in the prior-year period — up 34.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-93M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Five Prime Therapeutics, and consider following FPRX for alerts when major investors trade the stock.

Five Prime Therapeutics is classified in the Healthcare sector. On operating income, it currently shows $-93M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FPRX with unrelated industries.